期刊文献+

坏疽性脓皮病治疗现状与进展 被引量:33

Current Situation and Progress in the Treatment for Pyoderma Gangrenosum
暂未订购
导出
摘要 坏疽性脓皮病(PG)治疗方法众多,一般以系统治疗为主,主要包括皮质类固醇激素、免疫抑制剂、生物制剂和细胞祛除法等,其中皮质类固醇激素目前是治疗坏疽性脓皮病的一线药物,免疫抑制剂可单独也可联合皮质类固醇激素使用,生物制剂和细胞祛除法等是新近研究发现可治疗PG的方法,在部分患者中也取得良好疗效。局部治疗作为系统治疗的辅助治疗,在症状较轻时也可单独使用。 The treatment for pyoderma gangrenosum is various, but system treatment is the mainstream method, including corticosteroid,immunosuppressant,biologic agent,granulocytapheresis ( GCAP), leukocytapheresis (LCAP) and so on. The first line drug for PG is corticosteroid, lmmunosuppressant can be used in PG alone or with corticosteroid. Biologic agent, GCAP and LCAP which are new methods for the treatment of PG have been found can get satisfied result in some patients. Topical treatment, as a subsidiary method, can be used in some patients with minor symptoms.
作者 陈传杰 陆春
出处 《中国皮肤性病学杂志》 CAS 北大核心 2010年第2期175-177,共3页 The Chinese Journal of Dermatovenereology
关键词 坏疽性脓皮病 皮质类固醇激素 免疫抑制剂 Pyoderma gangrenosum Corticosteroid Immunosuppressant
  • 相关文献

参考文献22

  • 1Reynoso-Von Drateln C, Perla-Navarro AV, Gamez-Nava JI,et al. Intravenous cyclophosphamide pulses in pyoderma gangrenosum: an open trial [ J ]. J Rheumatol, 1997,24 (4) :689 -693.
  • 2Schmidt C, Wittig BM, Moser C, et al. Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces longterm remission in patients with steroid-refractory Crohn's disease. Alimentary[ J]. Pharmacology and Therapeutics, 2006, 24 (2) : 343 - 350,358.
  • 3Daniels NH, Callen JP. Mycophenolate mofetil is an effective treatment for pefistomal pyoderma gangrenosum [ J ]. Arch Dermatol, 2004, 140(12) :1427 - 1429.
  • 4Baumgart DC, Wiedenmann B, Dignass AU. Successful therapy of refractory pyoderma gangrenosum and periorbital phlegmona with tacrolimus ( FKS06 ) in ulcerative colitis [ J ]. Inflamm Bowel Dis, 2004,10(4) :421 -424.
  • 5Brooklyn TN, Dunnill MG, Shetty A, et al. Infliximab for the treatment of pyoderma gangrenosum : a randomised, double blind, placebo controlled trial[ J]. Gut, 2006, 55(4) :505 -509.
  • 6Mcgowan JW, Johnson CA, Lynn A. Treatment of pyoderma gangrenosum with Etanercept[J]. J Drugs Dermatol, 2004, 3:441 -444.
  • 7Hubbard VG, Friedmann AC, Goldsmith P. Systemic pyoderma gangrenosum responding to infliximab and adalimumab [ J ], British Journal of Dermatology, 2005, 152 ( 5 ) : 1059 - 1061.
  • 8Fonder MA, Cummins DL, Ehst BD, et al. Adalimumab therapy for recalcitrant pyoderma gangrenosum [ J ]. J Burns Wounds, 2006 ,20(5) :eS.
  • 9Teasley LA, Foster CS, Bahatzis S. Sclerokeratitis and facial skin leslons : a case report of pyoderma gangrenosum and its response to dapsone therapy [ J ]. Cornea, 2007, 26 (2) : 215 -219.
  • 10Asahina A, Minatani Y, Tada Y, et al. Successful treatment of pyoderma gangrenosum with potassium iodide[ J]. Acta Derm Venereol, 2006,86( 1 ) :84 - 85.

同被引文献122

引证文献33

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部